PRIME THERAPEUTICS: Earns URAC accreditation in pharmacy benefit management

Prime Therapeutics issued the following announcement on May 17.

Prime Therapeutics LLC (Prime) announces it has earned URAC accreditation in Pharmacy Benefit Management (PBM).  URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. By achieving this status, Prime has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.

Prime has been providing PBM services for more than 20 years and now serves more than 28 million members nationally.  Its mission is to make health care work better and help people get the medicine they need to feel better and live well.  The company regularly pursues several accreditations to help improve service quality, and examine processes that enhance operations and compliance.

"As a company focused on providing total drug management, we aim to service our health plan and employer clients with the utmost quality," said Renee Treberg, Chief Compliance Officer. "We are extremely proud to have been reaccredited by URAC in Pharmacy Benefit Management as it represents the gold standard in our industry and validates that Prime provides solid, high quality programs for our clients and their members. We hope people will see the URAC seal and know that we've been evaluated in a rigorous, meaningful way and that they can be confident doing business with us."

URAC accreditation requires applicants to submit policies, procedures, and other organizational information that is followed by a review. The accreditation process demonstrates a commitment to quality services and serves as a framework to improve business processes through benchmarking organizations against nationally recognized standards.

"URAC accreditation shows that Prime is a pharmacy benefit management organization able to adhere to standards that cover important aspects of care such as claims processing, developing proper drug formulary, and consumer access," said URAC President and CEO Shawn Griffin, M.D. "Quality policies and procedures are paramount as the price and complexity of medications rise. Prime Therapeutics chose to demonstrate their performance through URAC's independent accreditation of their services."

Prime's accreditation is valid Jan. 1, 2019through Jan. 1, 2022.

Original source can be found here.

Want to get notified whenever we write about Prime Therapeutics ?
Next time we write about Prime Therapeutics, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Prime Therapeutics 1305 Corporate Center Drive Eagan, Minnesota 55121